🇨🇦 KJX839 in Canada

KJX839 (KJX839) regulatory status in Canada.

Marketing authorisation

KJX839 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in Canada

Frequently asked questions

Is KJX839 approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for KJX839 in Canada?

Novartis Pharmaceuticals is the originator. The local marketing authorisation holder may differ — check the official source linked above.